• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于拓扑数据分析的方法鉴定出具有独特突变特征和良好预后的乳腺癌亚群。

Topology based data analysis identifies a subgroup of breast cancers with a unique mutational profile and excellent survival.

机构信息

Department of Mathematics, Stanford University, Stanford, CA 94305, USA.

出版信息

Proc Natl Acad Sci U S A. 2011 Apr 26;108(17):7265-70. doi: 10.1073/pnas.1102826108. Epub 2011 Apr 11.

DOI:10.1073/pnas.1102826108
PMID:21482760
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3084136/
Abstract

High-throughput biological data, whether generated as sequencing, transcriptional microarrays, proteomic, or other means, continues to require analytic methods that address its high dimensional aspects. Because the computational part of data analysis ultimately identifies shape characteristics in the organization of data sets, the mathematics of shape recognition in high dimensions continues to be a crucial part of data analysis. This article introduces a method that extracts information from high-throughput microarray data and, by using topology, provides greater depth of information than current analytic techniques. The method, termed Progression Analysis of Disease (PAD), first identifies robust aspects of cluster analysis, then goes deeper to find a multitude of biologically meaningful shape characteristics in these data. Additionally, because PAD incorporates a visualization tool, it provides a simple picture or graph that can be used to further explore these data. Although PAD can be applied to a wide range of high-throughput data types, it is used here as an example to analyze breast cancer transcriptional data. This identified a unique subgroup of Estrogen Receptor-positive (ER(+)) breast cancers that express high levels of c-MYB and low levels of innate inflammatory genes. These patients exhibit 100% survival and no metastasis. No supervised step beyond distinction between tumor and healthy patients was used to identify this subtype. The group has a clear and distinct, statistically significant molecular signature, it highlights coherent biology but is invisible to cluster methods, and does not fit into the accepted classification of Luminal A/B, Normal-like subtypes of ER(+) breast cancers. We denote the group as c-MYB(+) breast cancer.

摘要

高通量生物数据,无论是测序、转录微阵列、蛋白质组学还是其他方法产生的,都需要分析方法来解决其高维方面的问题。由于数据分析的计算部分最终确定了数据集组织中的形状特征,因此高维形状识别的数学仍然是数据分析的关键部分。本文介绍了一种从高通量微阵列数据中提取信息的方法,通过使用拓扑学,提供了比当前分析技术更深入的信息。该方法称为疾病进展分析(PAD),首先识别聚类分析中的稳健方面,然后深入挖掘这些数据中的多种生物学有意义的形状特征。此外,由于 PAD 包含可视化工具,因此它提供了一个简单的图像或图表,可以用于进一步探索这些数据。虽然 PAD 可以应用于广泛的高通量数据类型,但本文将其作为示例来分析乳腺癌转录数据。这确定了一组独特的雌激素受体阳性(ER(+))乳腺癌,这些肿瘤表达高水平的 c-MYB 和低水平的固有炎症基因。这些患者的存活率为 100%,没有转移。没有使用超出肿瘤和健康患者区分的监督步骤来识别这种亚型。该组具有明确且显著的分子特征,突出了连贯的生物学,但对聚类方法不可见,也不符合 ER(+)乳腺癌的 Luminal A/B、正常样亚型的公认分类。我们将该组命名为 c-MYB(+)乳腺癌。

相似文献

1
Topology based data analysis identifies a subgroup of breast cancers with a unique mutational profile and excellent survival.基于拓扑数据分析的方法鉴定出具有独特突变特征和良好预后的乳腺癌亚群。
Proc Natl Acad Sci U S A. 2011 Apr 26;108(17):7265-70. doi: 10.1073/pnas.1102826108. Epub 2011 Apr 11.
2
Mechanism of and requirement for estrogen-regulated MYB expression in estrogen-receptor-positive breast cancer cells.雌激素受体阳性乳腺癌细胞中雌激素调节MYB表达的机制及需求
Proc Natl Acad Sci U S A. 2007 Aug 21;104(34):13762-7. doi: 10.1073/pnas.0700104104. Epub 2007 Aug 9.
3
Genes responsive to both oxidant stress and loss of estrogen receptor function identify a poor prognosis group of estrogen receptor positive primary breast cancers.对氧化应激和雌激素受体功能丧失均有反应的基因可识别出雌激素受体阳性原发性乳腺癌的一个预后不良组。
Breast Cancer Res. 2008;10(4):R61. doi: 10.1186/bcr2120. Epub 2008 Jul 17.
4
Meta-analysis and gene set enrichment relative to er status reveal elevated activity of MYC and E2F in the "basal" breast cancer subgroup.相对于雌激素受体(ER)状态的荟萃分析和基因集富集分析显示,在“基底样”乳腺癌亚组中,MYC和E2F的活性升高。
PLoS One. 2009;4(3):e4710. doi: 10.1371/journal.pone.0004710. Epub 2009 Mar 9.
5
Posttranscriptional regulation of the c-myb proto-oncogene in estrogen receptor-positive breast cancer cells.雌激素受体阳性乳腺癌细胞中c-myb原癌基因的转录后调控
Clin Cancer Res. 1995 Feb;1(2):235-43.
6
FOXA1 expression in breast cancer--correlation with luminal subtype A and survival.乳腺癌中FOXA1的表达——与腔面A型及生存的相关性
Clin Cancer Res. 2007 Aug 1;13(15 Pt 1):4415-21. doi: 10.1158/1078-0432.CCR-07-0122.
7
[The expression of c-myb is strongly associated with the presence of estrogen and progesterone receptors in breast cancer].c-myb的表达与乳腺癌中雌激素和孕激素受体的存在密切相关。
C R Acad Sci III. 1988;307(20):855-61.
8
A three-gene model to robustly identify breast cancer molecular subtypes.一种稳健识别乳腺癌分子亚型的三基因模型。
J Natl Cancer Inst. 2012 Feb 22;104(4):311-25. doi: 10.1093/jnci/djr545. Epub 2012 Jan 18.
9
A modular analysis of breast cancer reveals a novel low-grade molecular signature in estrogen receptor-positive tumors.一项乳腺癌的模块化分析揭示了雌激素受体阳性肿瘤中一种新的低级别分子特征。
Clin Cancer Res. 2006 Jun 1;12(11 Pt 1):3288-96. doi: 10.1158/1078-0432.CCR-05-1530.
10
Identification and regulation of c-Myb target genes in MCF-7 cells.鉴定和调控 MCF-7 细胞中的 c-Myb 靶基因。
BMC Cancer. 2011 Jan 25;11:30. doi: 10.1186/1471-2407-11-30.

引用本文的文献

1
Topological Data Analysis Reveals a Subgroup of Luminal B Breast Cancer.拓扑数据分析揭示了腔面B型乳腺癌的一个亚组。
IEEE Open J Eng Med Biol. 2025 May 21;6:465-471. doi: 10.1109/OJEMB.2025.3558670. eCollection 2025.
2
Position: Topological Deep Learning is the New Frontier for Relational Learning.观点:拓扑深度学习是关系学习的新前沿。
Proc Mach Learn Res. 2024 Jul;235:39529-39555.
3
A novel method for subgroup discovery in precision medicine based on topological data analysis.一种基于拓扑数据分析的精准医学亚组发现新方法。
BMC Med Inform Decis Mak. 2025 Mar 19;25(1):139. doi: 10.1186/s12911-025-02852-9.
4
A distribution-guided Mapper algorithm.一种分布引导的映射器算法。
BMC Bioinformatics. 2025 Mar 5;26(1):73. doi: 10.1186/s12859-025-06085-5.
5
Simplicity within biological complexity.生物复杂性中的简单性。
Bioinform Adv. 2025 Feb 6;5(1):vbae164. doi: 10.1093/bioadv/vbae164. eCollection 2025.
6
EiDA: A lossless approach for dynamic functional connectivity; application to fMRI data of a model of ageing.EiDA:一种用于动态功能连接性的无损方法;应用于衰老模型的功能磁共振成像数据。
Imaging Neurosci (Camb). 2024 Mar 22;2:1-22. doi: 10.1162/imag_a_00113. eCollection 2024 Mar 1.
7
Deconstructing the Mapper algorithm to extract richer topological and temporal features from functional neuroimaging data.解构Mapper算法以从功能神经影像数据中提取更丰富的拓扑和时间特征。
Netw Neurosci. 2024 Dec 10;8(4):1355-1382. doi: 10.1162/netn_a_00403. eCollection 2024.
8
Hierarchical simplicial manifold learning.分层单纯形流形学习
PNAS Nexus. 2024 Nov 28;3(12):pgae530. doi: 10.1093/pnasnexus/pgae530. eCollection 2024 Dec.
9
Mitigating bias in radiology: The promise of topological data analysis and simplicial complexes.减少放射学中的偏倚:拓扑数据分析和单纯复形的应用前景。
Oncotarget. 2024 Nov 12;15:782-783. doi: 10.18632/oncotarget.28668.
10
Transcriptional regulatory program controlled by MYB in T-cell acute lymphoblastic leukemia.MYB 调控的 T 细胞急性淋巴细胞白血病转录调控程序。
Leukemia. 2024 Dec;38(12):2573-2584. doi: 10.1038/s41375-024-02455-9. Epub 2024 Nov 2.

本文引用的文献

1
Mitochondrial Hep27 is a c-Myb target gene that inhibits Mdm2 and stabilizes p53.线粒体 Hep27 是 c-Myb 的靶基因,可抑制 Mdm2 并稳定 p53。
Mol Cell Biol. 2010 Aug;30(16):3981-93. doi: 10.1128/MCB.01284-09. Epub 2010 Jun 14.
2
Supervised risk predictor of breast cancer based on intrinsic subtypes.基于内在亚型的乳腺癌监督风险预测器
J Clin Oncol. 2009 Mar 10;27(8):1160-7. doi: 10.1200/JCO.2008.18.1370. Epub 2009 Feb 9.
3
The functional loss of the retinoblastoma tumour suppressor is a common event in basal-like and luminal B breast carcinomas.视网膜母细胞瘤肿瘤抑制因子的功能丧失在基底样和腔面B型乳腺癌中是常见事件。
Breast Cancer Res. 2008;10(5):R75. doi: 10.1186/bcr2142. Epub 2008 Sep 9.
4
Structural insight into RNA hairpin folding intermediates.对RNA发夹折叠中间体的结构洞察。
J Am Chem Soc. 2008 Jul 30;130(30):9676-8. doi: 10.1021/ja8032857. Epub 2008 Jul 1.
5
MYB function in normal and cancer cells.MYB在正常细胞和癌细胞中的功能。
Nat Rev Cancer. 2008 Jul;8(7):523-34. doi: 10.1038/nrc2439.
6
TP53 mutation status and gene expression profiles are powerful prognostic markers of breast cancer.TP53突变状态和基因表达谱是乳腺癌强有力的预后标志物。
Breast Cancer Res. 2007;9(3):R30. doi: 10.1186/bcr1675.
7
Disease-specific genomic analysis: identifying the signature of pathologic biology.疾病特异性基因组分析:识别病理生物学特征
Bioinformatics. 2007 Apr 15;23(8):957-65. doi: 10.1093/bioinformatics/btm033. Epub 2007 Feb 3.
8
Repeated observation of breast tumor subtypes in independent gene expression data sets.在独立基因表达数据集中对乳腺肿瘤亚型的重复观察。
Proc Natl Acad Sci U S A. 2003 Jul 8;100(14):8418-23. doi: 10.1073/pnas.0932692100. Epub 2003 Jun 26.
9
A gene-expression signature as a predictor of survival in breast cancer.一种作为乳腺癌生存预测指标的基因表达特征。
N Engl J Med. 2002 Dec 19;347(25):1999-2009. doi: 10.1056/NEJMoa021967.
10
Diagnosis of multiple cancer types by shrunken centroids of gene expression.通过基因表达的收缩质心诊断多种癌症类型。
Proc Natl Acad Sci U S A. 2002 May 14;99(10):6567-72. doi: 10.1073/pnas.082099299.